Stockreport

Beam Therapeutics to Participate in 2024 Jefferies London Healthcare Conference

Beam Therapeutics Inc.  (BEAM) 
PDF CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base [Read more]